ABRUPT DISCONTINUATION OF CLONIDINE THERAPY

被引:17
作者
RAM, CVS [1 ]
ENGELMAN, K [1 ]
机构
[1] HOSP UNIV PENN,HYPERTENS & CLIN PHARMACOL SECT,PHILADELPHIA,PA 19104
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1979年 / 242卷 / 19期
关键词
D O I
10.1001/jama.242.19.2104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2104 / 2105
页数:2
相关论文
共 6 条
[1]  
HOOBLER SW, 1977, MAYO CLIN PROC, V52, P395
[2]   EFFECTS OF CLONIDINE WITHDRAWAL - POSSIBLE MECHANISMS AND SUGGESTIONS FOR MANAGEMENT [J].
HUNYOR, SN ;
HANSSON, L ;
HARRISON, TS ;
HOOBLER, SW .
BRITISH MEDICAL JOURNAL, 1973, 2 (5860) :209-211
[3]   DRUG-THERAPY - CLONIDINE, A NEW ANTIHYPERTENSIVE DRUG [J].
PETTINGER, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (23) :1179-1180
[4]  
REID JL, 1977, LANCET, V1, P1171
[5]   LOCALIZATION OF HYPOTENSIVE EFFECT OF 2-(2-6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST-155 CATAPRESAN) [J].
SCHMITT, H ;
SCHMITT, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 6 (01) :8-&
[6]  
STRAUSS FG, 1977, JAMA-J AM MED ASSOC, V238, P1734